Clinical trial

PriMatrix for the Management of Diabetic Foot Ulcers

NCT03010319

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-01-01

PhaseNA

Study timeline

Study start (actual)2017-01-01Date precision: month

Registry last updated2022-04-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Foot Ulcerunresolved

Interventions

PriMatrix Dermal Repair ScaffoldDEVICE

Secondary DressingsDEVICE

Offloading deviceDEVICE

Sponsors & collaborators

Integra LifeSciences Corporationlead sponsor

Mapped research locations

DallasTexas, United States2 New YorkNew York, United States1 Los AngelesCalifornia, United States1 San AntonioTexas, United States1 San FranciscoCalifornia, United States1 Washington D.C.District of Columbia, United States1 Fort WorthTexas, United States1 TulsaOklahoma, United States1 West Palm BeachFlorida, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03010319 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.